PNU-100480

· Sequella, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PNU-100480, covering 2013-08-27 to 2016-01-14. Get the full timeline:

Most recent: Clinical Trial Update: PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay [Phase 2]

See pricing